Page last updated: 2024-08-24

triazoles and Hypermelanosis

triazoles has been researched along with Hypermelanosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cohen, PR	1
Katznelson, L	1

Other Studies

2 other study(ies) available for triazoles and Hypermelanosis

Article	Year
Melasma treatment: A novel approach using a topical agent that contains an anti-estrogen and a vascular endothelial growth factor inhibitor. Medical hypotheses, 2017, Volume: 101 Topics: Administration, Topical; Anastrozole; Androstadienes; Aromatase Inhibitors; Estrogens; Female; Genetic Predisposition to Disease; Humans; Hyperpigmentation; Letrozole; Male; Melanosis; Neovascularization, Pathologic; Nitriles; Pregnancy; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles; Ultraviolet Rays; Vascular Endothelial Growth Factor A	2017
Sustained improvements in plasma ACTH and clinical status in a patient with Nelson's syndrome treated with pasireotide LAR, a multireceptor somatostatin analog. The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:5 Topics: Adrenocorticotropic Hormone; Central Nervous System Cysts; Delayed-Action Preparations; Dipeptidyl-Peptidase IV Inhibitors; Female; Growth Hormone-Releasing Hormone; Humans; Hyperglycemia; Hyperpigmentation; Middle Aged; Nelson Syndrome; Pyrazines; Severity of Illness Index; Sitagliptin Phosphate; Somatostatin; Treatment Outcome; Triazoles	2013

Article

Year

Melasma treatment: A novel approach using a topical agent that contains an anti-estrogen and a vascular endothelial growth factor inhibitor.

Medical hypotheses, 2017, Volume: 101

Topics: Administration, Topical; Anastrozole; Androstadienes; Aromatase Inhibitors; Estrogens; Female; Genetic Predisposition to Disease; Humans; Hyperpigmentation; Letrozole; Male; Melanosis; Neovascularization, Pathologic; Nitriles; Pregnancy; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles; Ultraviolet Rays; Vascular Endothelial Growth Factor A

2017

Sustained improvements in plasma ACTH and clinical status in a patient with Nelson's syndrome treated with pasireotide LAR, a multireceptor somatostatin analog.

The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:5

Topics: Adrenocorticotropic Hormone; Central Nervous System Cysts; Delayed-Action Preparations; Dipeptidyl-Peptidase IV Inhibitors; Female; Growth Hormone-Releasing Hormone; Humans; Hyperglycemia; Hyperpigmentation; Middle Aged; Nelson Syndrome; Pyrazines; Severity of Illness Index; Sitagliptin Phosphate; Somatostatin; Treatment Outcome; Triazoles

2013